
Opinion|Videos|March 26, 2024
Overview of ARPIs in the Treatment of Prostate Cancer
Author(s)Matthew Smith, MD, PhD, Brian Helfand, MD, PhD
Comprehensive insights on ARPIs (androgen receptor pathway inhibitors) for the treatment of prostate cancer, highlighting what influences treatment decisions and safety profiles of the available APRIs.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
2
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
3
Mary Dunn, MSN, NP-C, OCN, RN, on advances reshaping advanced prostate cancer care
4
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
5











